Litani, Inc. – Trademark Portfolio

Entity Type: 03

Litani, Inc. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 7 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include DREAM TAN, DREAM GIRL, VAZKULIZER, BRONZE ANGEL, and BRONZE KNIGHT. The owner is based in RESEDA, CA.

6860 CANBY AVE STE 116

RESEDA, CA 91335

9 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Litani, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (7 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Litani, Inc. have?

Litani, Inc. has 9 U.S. trademarks filed with the USPTO. Of these, 6 registered, 3 cancelled.

What trademark classes does Litani, Inc. file in?

Litani, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are Litani, Inc.'s most well-known trademarks?

Litani, Inc.'s registered trademark portfolio includes well-known marks such as DREAM TAN, DREAM GIRL, VAZKULIZER, BRONZE ANGEL, and BRONZE KNIGHT. These are among 6 currently registered trademarks in the portfolio.

What is Litani, Inc.'s trademark registration success rate?

Litani, Inc. has a 67% trademark registration rate, with 6 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.